-
1
-
-
0024431679
-
The current status of neuroleptic therapy
-
Kane JM: The current status of neuroleptic therapy. J. Clin. Psychiatry 50(9), 322-328 (1989).
-
(1989)
J. Clin. Psychiatry
, vol.50
, Issue.9
, pp. 322-328
-
-
Kane, J.M.1
-
2
-
-
0035065899
-
Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: A review and meta-analysis of randomized trials
-
Chakos M, Lieberman J, Hoffman E, Bradford D, Sheitman B: Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Am. J. Psychiatry 158(4), 518-526 (2001).
-
(2001)
Am. J. Psychiatry
, vol.158
, Issue.4
, pp. 518-526
-
-
Chakos, M.1
Lieberman, J.2
Hoffman, E.3
Bradford, D.4
Sheitman, B.5
-
3
-
-
0023812652
-
Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine
-
Kane J, Honigfeld G, Singer J, Meltzer H: Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch. Gen. Psychiatry 45(9), 789-796 (1988).
-
(1988)
Arch. Gen. Psychiatry
, vol.45
, Issue.9
, pp. 789-796
-
-
Kane, J.1
Honigfeld, G.2
Singer, J.3
Meltzer, H.4
-
4
-
-
0031417026
-
Treatment-resistant schizophrenia - The role of clozapine
-
Meltzer HY: Treatment-resistant schizophrenia - the role of clozapine. Curr. Med. Res. Opin. 14(1), 1-20 (1997).
-
(1997)
Curr. Med. Res. Opin.
, vol.14
, Issue.1
, pp. 1-20
-
-
Meltzer, H.Y.1
-
5
-
-
0033008580
-
Evidence of clozapine's effectiveness in schizophrenia: A systematic review and meta-analysis of randomized trials
-
Wahlbeck K, Cheine M, Essali A, Adams C: Evidence of clozapine's effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials. Am. J. Psychiatry 156(7), 990-999 (1999).
-
(1999)
Am. J. Psychiatry
, vol.156
, Issue.7
, pp. 990-999
-
-
Wahlbeck, K.1
Cheine, M.2
Essali, A.3
Adams, C.4
-
6
-
-
0001962034
-
Receptor profile of antipsychotics
-
Ellenbroek BA, Cools AR (Eds). Bikhauser Verlag, Basel, Switzerland
-
Leysen JE: Receptor profile of antipsychotics. In:Atypical Antipsychotics , Ellenbroek BA, Cools AR (Eds). Bikhauser Verlag, Basel, Switzerland, 57-81 (2000).
-
(2000)
Atypical Antipsychotics
, pp. 57-81
-
-
Leysen, J.E.1
-
7
-
-
11844286960
-
Mechanisms of action of second generation antipsychotic drugs in schizophrenia: Insights from brain imaging studies
-
Abi-Dargham A, Laruelle M: Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studies. Eur. Psychiatry 20(1), 15-27 (2005).
-
(2005)
Eur. Psychiatry
, vol.20
, Issue.1
, pp. 15-27
-
-
Abi-Dargham, A.1
Laruelle, M.2
-
8
-
-
0025286232
-
Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress
-
Deutch AY, Clark WA, Roth RH: Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress. Brain Res. 521(1-2), 311-315 (1990).
-
(1990)
Brain Res.
, vol.521
, Issue.1-2
, pp. 311-315
-
-
Deutch, A.Y.1
Clark, W.A.2
Roth, R.H.3
-
9
-
-
0036177183
-
Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia
-
Meyer-Lindenberg A, Miletich RS, Kohn PD et al.: Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nat. Neurosci. 5(3), 267-271 (2002).
-
(2002)
Nat. Neurosci.
, vol.5
, Issue.3
, pp. 267-271
-
-
Meyer-Lindenberg, A.1
Miletich, R.S.2
Kohn, P.D.3
-
10
-
-
0019190758
-
Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats
-
Pycock CJ, Kerwin RW, Carter CJ: Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats. Nature 286(5768), 74-76 (1980).
-
(1980)
Nature
, vol.286
, Issue.5768
, pp. 74-76
-
-
Pycock, C.J.1
Kerwin, R.W.2
Carter, C.J.3
-
11
-
-
0023215296
-
Implications of normal brain development for the pathogenesis of schizophrenia
-
Weinberger DR: Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry 44(7), 660-669 (1987).
-
(1987)
Arch. Gen. Psychiatry
, vol.44
, Issue.7
, pp. 660-669
-
-
Weinberger, D.R.1
-
12
-
-
0023732007
-
Organization of dopamine D1 and D2 receptors in human striatum: Receptor autoradiographic studies in huntington's disease and schizophrenia
-
Joyce JN, Lexow N, Bird E, Winokur A: Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in huntington's disease and schizophrenia. Synapse 2(5), 546-557 (1988).
-
(1988)
Synapse
, vol.2
, Issue.5
, pp. 546-557
-
-
Joyce, J.N.1
Lexow, N.2
Bird, E.3
Winokur, A.4
-
13
-
-
26644464161
-
Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations
-
Rationale and single polymorphism association results for DRD2 polymorphisms used in the present study
-
Hwang R, Shinkai T, De Luca V et al.: Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations. Psychopharmacology (Berl.) 181(1), 179-187 (2005). Rationale and single polymorphism association results for DRD2 polymorphisms used in the present study.
-
(2005)
Psychopharmacology (Berl.)
, vol.181
, Issue.1
, pp. 179-187
-
-
Hwang, R.1
Shinkai, T.2
De Luca, V.3
-
14
-
-
34548854787
-
Association study of four dopamine D1 receptor gene polymorphisms and clozapine treatment response
-
Detailed description of the clinical sample, rationale and single polymorphism association results for DRD1 polymorphisms used in the present study
-
Hwang R, Shinkai T, De Luca V et al.: Association study of four dopamine D1 receptor gene polymorphisms and clozapine treatment response. J. Psychopharmacol. 21(7), 718-727 (2007). Detailed description of the clinical sample, rationale and single polymorphism association results for DRD1 polymorphisms used in the present study.
-
(2007)
J. Psychopharmacol.
, vol.21
, Issue.7
, pp. 718-727
-
-
Hwang, R.1
Shinkai, T.2
De Luca, V.3
-
15
-
-
77952887880
-
Effect of dopamine D3 receptor gene polymorphisms and clozapine treatment response: Exploratory analysis of nine polymorphisms and meta-analysis of the Ser9Gly variant
-
Rationale and single polymorphism association results for DRD3 polymorphisms used in the present study
-
Hwang R, Zai C, Tiwari A et al.: Effect of dopamine D3 receptor gene polymorphisms and clozapine treatment response: exploratory analysis of nine polymorphisms and meta-analysis of the Ser9Gly variant. Pharmacogenomics J. 10(3), 200-218 (2009). Rationale and single polymorphism association results for DRD3 polymorphisms used in the present study.
-
(2009)
Pharmacogenomics J.
, vol.10
, Issue.3
, pp. 200-218
-
-
Hwang, R.1
Zai, C.2
Tiwari, A.3
-
16
-
-
0027332950
-
Anti-glutamatergic effects of clozapine
-
Lidsky TI, Yablonsky-Alter E, Zuck L, Banerjee SP: Anti-glutamatergic effects of clozapine. Neurosci. Lett. 163(2), 155-158 (1993).
-
(1993)
Neurosci. Lett.
, vol.163
, Issue.2
, pp. 155-158
-
-
Lidsky, T.I.1
Yablonsky-Alter, E.2
Zuck, L.3
Banerjee, S.P.4
-
17
-
-
0031800006
-
M100907 and clozapine, but not haloperidol or raclopride, prevent phencyclidine-induced blockade of NMDA responses in pyramidal neurons of the rat medial prefrontal cortical slice
-
Wang RY, Liang X: M100907 and clozapine, but not haloperidol or raclopride, prevent phencyclidine-induced blockade of NMDA responses in pyramidal neurons of the rat medial prefrontal cortical slice. Neuropsychopharmacology 19(1), 74-85 (1998).
-
(1998)
Neuropsychopharmacology
, vol.19
, Issue.1
, pp. 74-85
-
-
Wang, R.Y.1
Liang, X.2
-
18
-
-
0030881619
-
Clozapine and haloperidol modulate N-methyl-D-aspartate- and non-N-methyl-D-aspartate receptor-mediated neurotransmission in rat prefrontal cortical neurons in vitro
-
Arvanov VL, Liang X, Schwartz J, Grossman S, Wang RY: Clozapine and haloperidol modulate N-methyl-D-aspartate- and non-N-methyl-D-aspartate receptor-mediated neurotransmission in rat prefrontal cortical neurons in vitro. J. Pharmacol. Exp. Ther. 283(1), 226-234 (1997).
-
(1997)
J. Pharmacol. Exp. Ther.
, vol.283
, Issue.1
, pp. 226-234
-
-
Arvanov, V.L.1
Liang, X.2
Schwartz, J.3
Grossman, S.4
Wang, R.Y.5
-
19
-
-
0025952455
-
Recent advances in the phencyclidine model of schizophrenia
-
Javitt DC, Zukin SR: Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 148(10), 1301-1308 (1991).
-
(1991)
Am. J. Psychiatry
, vol.148
, Issue.10
, pp. 1301-1308
-
-
Javitt, D.C.1
Zukin, S.R.2
-
20
-
-
0028850552
-
Glutamate receptor dysfunction and schizophrenia
-
Olney JW, Farber NB: Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiatry 52(12), 998-1007 (1995).
-
(1995)
Arch. Gen. Psychiatry
, vol.52
, Issue.12
, pp. 998-1007
-
-
Olney, J.W.1
Farber, N.B.2
-
21
-
-
0029557350
-
Glutamate pharmacology and the treatment of schizophrenia: Current status and future directions
-
Tamminga CA, Holcomb HH, Gao XM, Lahti AC: Glutamate pharmacology and the treatment of schizophrenia: Current status and future directions. Int. Clin. Psychopharmacol. 10(Suppl. 3), 29-37 (1995).
-
(1995)
Int. Clin. Psychopharmacol.
, vol.10
, Issue.SUPPL. 3
, pp. 29-37
-
-
Tamminga, C.A.1
Holcomb, H.H.2
Gao, X.M.3
Lahti, A.C.4
-
22
-
-
30544437565
-
Effects of haloperidol, clozapine, and quetiapine on sensorimotor gating in a genetic model of reduced NMDA receptor function
-
Duncan GE, Moy SS, Lieberman JA, Koller BH: Effects of haloperidol, clozapine, and quetiapine on sensorimotor gating in a genetic model of reduced NMDA receptor function. Psychopharmacology (Berl.) 184(2), 190-200 (2006).
-
(2006)
Psychopharmacology (Berl.)
, vol.184
, Issue.2
, pp. 190-200
-
-
Duncan, G.E.1
Moy, S.S.2
Lieberman, J.A.3
Koller, B.H.4
-
23
-
-
33947511870
-
Clozapine treatment reverses dizocilpine-induced deficits of pre-pulse inhibition of tactile startle response
-
Levin ED, Caldwell DP, Perraut C: Clozapine treatment reverses dizocilpine-induced deficits of pre-pulse inhibition of tactile startle response. Pharmacol. Biochem. Behav. 86(3), 597-605 (2007).
-
(2007)
Pharmacol. Biochem. Behav.
, vol.86
, Issue.3
, pp. 597-605
-
-
Levin, E.D.1
Caldwell, D.P.2
Perraut, C.3
-
24
-
-
44449175118
-
Repeated low dose of phencyclidine administration impairs spatial learning in mice: Blockade by clozapine but not by haloperidol
-
Beraki S, Kuzmin A, Tai F, Ogren SO: Repeated low dose of phencyclidine administration impairs spatial learning in mice: blockade by clozapine but not by haloperidol. Eur. Neuropsychopharmacol. 18(7), 486-497 (2008).
-
(2008)
Eur. Neuropsychopharmacol.
, vol.18
, Issue.7
, pp. 486-497
-
-
Beraki, S.1
Kuzmin, A.2
Tai, F.3
Ogren, S.O.4
-
25
-
-
0030608074
-
Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity
-
Farber NB, Foster J, Duhan NL, Olney JW: Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity. Schizophr. Res. 21(1), 33-37 (1996).
-
(1996)
Schizophr. Res.
, vol.21
, Issue.1
, pp. 33-37
-
-
Farber, N.B.1
Foster, J.2
Duhan, N.L.3
Olney, J.W.4
-
26
-
-
0027249274
-
Antipsychotic drugs block phencyclidine receptor-mediated neurotoxicity
-
Farber NB, Price MT, Labruyere J et al.: Antipsychotic drugs block phencyclidine receptor-mediated neurotoxicity. Biol. Psychiatry 34(1-2), 119-121 (1993).
-
(1993)
Biol. Psychiatry
, vol.34
, Issue.1-2
, pp. 119-121
-
-
Farber, N.B.1
Price, M.T.2
Labruyere, J.3
-
27
-
-
38349167489
-
Abnormally persistent latent inhibition induced by MK801 is reversed by risperidone and by positive modulators of NMDA receptor function: Differential efficacy depending on the stage of the task at which they are administered
-
Gaisler-Salomon I, Diamant L, Rubin C, Weiner I: Abnormally persistent latent inhibition induced by MK801 is reversed by risperidone and by positive modulators of NMDA receptor function: differential efficacy depending on the stage of the task at which they are administered. Psychopharmacology (Berl.) 196(2), 255-267 (2008).
-
(2008)
Psychopharmacology (Berl.)
, vol.196
, Issue.2
, pp. 255-267
-
-
Gaisler-Salomon, I.1
Diamant, L.2
Rubin, C.3
Weiner, I.4
-
28
-
-
0028170896
-
New mechanisms of excitatory transmitter neurotoxicity
-
Olney JW: New mechanisms of excitatory transmitter neurotoxicity. J. Neural. Transm. Suppl. 43, 47-51 (1994).
-
(1994)
J. Neural. Transm. Suppl.
, vol.43
, pp. 47-51
-
-
Olney, J.W.1
-
29
-
-
0028089726
-
Efficacy of clozapine compared with other antipsychotics in preventing NMDA-antagonist neurotoxicity
-
Olney JW, Farber NB: Efficacy of clozapine compared with other antipsychotics in preventing NMDA-antagonist neurotoxicity. J. Clin. Psychiatry 55(Suppl. B), 43-46 (1994).
-
(1994)
J. Clin. Psychiatry
, vol.55
, Issue.SUPPL. B
, pp. 43-46
-
-
Olney, J.W.1
Farber, N.B.2
-
30
-
-
0033588463
-
Disruption of prepulse inhibition following N-methyl-D-aspartate infusion into the ventral hippocampus is antagonized by clozapine but not by haloperidol: A possible model for the screening of atypical antipsychotics
-
Zhang W, Pouzet B, Jongen-Relo AL, Weiner I, Feldon J: Disruption of prepulse inhibition following N-methyl-D-aspartate infusion into the ventral hippocampus is antagonized by clozapine but not by haloperidol: a possible model for the screening of atypical antipsychotics. Neuroreport 10(12), 2533-2538 (1999).
-
(1999)
Neuroreport
, vol.10
, Issue.12
, pp. 2533-2538
-
-
Zhang, W.1
Pouzet, B.2
Jongen-Relo, A.L.3
Weiner, I.4
Feldon, J.5
-
31
-
-
0029030343
-
Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonistinduced behaviors
-
Corbett R, Camacho F, Woods AT et al.: Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonistinduced behaviors. Psychopharmacology (Berl.) 120(1), 67-74 (1995).
-
(1995)
Psychopharmacology (Berl.)
, vol.120
, Issue.1
, pp. 67-74
-
-
Corbett, R.1
Camacho, F.2
Woods, A.T.3
-
32
-
-
25144509345
-
Mechanism of action of antipsychotic drugs: From dopamine D(2) receptor antagonism to glutamate NMDA facilitation
-
Functional interactions between glutamatergic and dopamine elements unify the key alterations postulated in schizophrenia
-
Laruelle M, Frankle WG, Narendran R, Kegeles LS, Abi-Dargham A: Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitation. Clin. Ther. 27(Suppl. A), S16-S24 (2005). Functional interactions between glutamatergic and dopamine elements unify the key alterations postulated in schizophrenia.
-
(2005)
Clin. Ther.
, vol.27
, Issue.SUPPL. A
-
-
Laruelle, M.1
Frankle, W.G.2
Narendran, R.3
Kegeles, L.S.4
Abi-Dargham, A.5
-
33
-
-
0032988563
-
A glutamatergic deficiency model of schizophrenia
-
Carlsson A, Hansson LO, Waters N, Carlsson ML: A glutamatergic deficiency model of schizophrenia. Br. J. Psychiatry Suppl. (37), 2-6 (1999).
-
(1999)
Br. J. Psychiatry Suppl.
, vol.37
, pp. 2-6
-
-
Carlsson, A.1
Hansson, L.O.2
Waters, N.3
Carlsson, M.L.4
-
34
-
-
0034307054
-
Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: Implications for schizophrenia
-
Kegeles LS, Abi-Dargham A, Zea-Ponce Y et al.: Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia. Biol. Psychiatry 48(7), 627-640 (2000).
-
(2000)
Biol. Psychiatry
, vol.48
, Issue.7
, pp. 627-640
-
-
Kegeles, L.S.1
Abi-Dargham, A.2
Zea-Ponce, Y.3
-
35
-
-
3543083733
-
Dopamine D1 and D2 receptor co-activation generates a novel phospholipase C-mediated calcium signal
-
Lee SP, So CH, Rashid AJ et al.: Dopamine D1 and D2 receptor co-activation generates a novel phospholipase C-mediated calcium signal. J. Biol. Chem. 279(34), 35671-35678 (2004).
-
(2004)
J. Biol. Chem.
, vol.279
, Issue.34
, pp. 35671-35678
-
-
Lee, S.P.1
So, C.H.2
Rashid, A.J.3
-
36
-
-
27744484748
-
Dopamine receptor oligomerization visualized in living cells
-
O'Dowd BF, Ji X, Alijaniaram M et al.: Dopamine receptor oligomerization visualized in living cells. J. Biol. Chem. 280(44), 37225-37235 (2005).
-
(2005)
J. Biol. Chem.
, vol.280
, Issue.44
, pp. 37225-37235
-
-
O'Dowd, B.F.1
Ji, X.2
Alijaniaram, M.3
-
37
-
-
23944467820
-
D1 and D2 dopamine receptors form heterooligomers and cointernalize after selective activation of either receptor
-
So CH, Varghese G, Curley KJ et al.: D1 and D2 dopamine receptors form heterooligomers and cointernalize after selective activation of either receptor. Mol. Pharmacol. 68(3), 568-578 (2005).
-
(2005)
Mol. Pharmacol.
, vol.68
, Issue.3
, pp. 568-578
-
-
So, C.H.1
Varghese, G.2
Curley, K.J.3
-
38
-
-
33846328669
-
D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum
-
Rashid AJ, So CH, Kong MM et al.: D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc. Natl Acad. Sci. USA 104(2), 654-659 (2007).
-
(2007)
Proc. Natl Acad. Sci. USA
, vol.104
, Issue.2
, pp. 654-659
-
-
Rashid, A.J.1
So, C.H.2
Kong, M.M.3
-
39
-
-
45649085857
-
Reciprocal regulation of dopamine D1 and D3 receptor function and trafficking by heterodimerization
-
Fiorentini C, Busi C, Gorruso E, Gotti C, Spano P, Missale C: Reciprocal regulation of dopamine D1 and D3 receptor function and trafficking by heterodimerization. Mol. Pharmacol. 74(1), 59-69 (2008).
-
(2008)
Mol. Pharmacol.
, vol.74
, Issue.1
, pp. 59-69
-
-
Fiorentini, C.1
Busi, C.2
Gorruso, E.3
Gotti, C.4
Spano, P.5
Missale, C.6
-
40
-
-
54449099573
-
Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum
-
Marcellino D, Ferre S, Casado V et al.: Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum. J. Biol. Chem. 283(38), 26016-26025 (2008).
-
(2008)
J. Biol. Chem.
, vol.283
, Issue.38
, pp. 26016-26025
-
-
Marcellino, D.1
Ferre, S.2
Casado, V.3
-
41
-
-
0142241355
-
Potent activation of dopamine D3/D2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropinirole
-
Maggio R, Scarselli M, Novi F, Millan MJ, Corsini GU: Potent activation of dopamine D3/D2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropinirole. J. Neurochem. 87(3), 631-641 (2003).
-
(2003)
J. Neurochem.
, vol.87
, Issue.3
, pp. 631-641
-
-
Maggio, R.1
Scarselli, M.2
Novi, F.3
Millan, M.J.4
Corsini, G.U.5
-
42
-
-
34547451141
-
Partial agonist actions of aripiprazole and the candidate antipsychotics S33592, bifeprunox, N-desmethylclozapine and preclamol at dopamine D(2L) receptors are modified by co-transfection of D(3) receptors: Potential role of heterodimer formation
-
Novi F, Millan MJ, Corsini GU, Maggio R: Partial agonist actions of aripiprazole and the candidate antipsychotics S33592, bifeprunox, N-desmethylclozapine and preclamol at dopamine D(2L) receptors are modified by co-transfection of D(3) receptors: potential role of heterodimer formation. J. Neurochem. 102(4), 1410-1424 (2007).
-
(2007)
J. Neurochem.
, vol.102
, Issue.4
, pp. 1410-1424
-
-
Novi, F.1
Millan, M.J.2
Corsini, G.U.3
Maggio, R.4
-
43
-
-
0035839599
-
D2/D3 dopamine receptor heterodimers exhibit unique functional properties
-
Scarselli M, Novi F, Schallmach E et al.: D2/D3 dopamine receptor heterodimers exhibit unique functional properties. J. Biol. Chem. 276(32), 30308-30314 (2001).
-
(2001)
J. Biol. Chem.
, vol.276
, Issue.32
, pp. 30308-30314
-
-
Scarselli, M.1
Novi, F.2
Schallmach, E.3
-
44
-
-
18644386370
-
Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor
-
Lee FJ, Xue S, Pei L et al.: Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor. Cell 111(2), 219-230 (2002).
-
(2002)
Cell
, vol.111
, Issue.2
, pp. 219-230
-
-
Lee, F.J.1
Xue, S.2
Pei, L.3
-
45
-
-
0038165500
-
Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-D-aspartate receptors
-
Fiorentini C, Gardoni F, Spano P, Di Luca M, Missale C: Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-D-aspartate receptors. J. Biol. Chem. 278(22), 20196-20202 (2003).
-
(2003)
J. Biol. Chem.
, vol.278
, Issue.22
, pp. 20196-20202
-
-
Fiorentini, C.1
Gardoni, F.2
Spano, P.3
Di Luca, M.4
Missale, C.5
-
46
-
-
34547664367
-
Modulation of D2R-NR2B interactions in response to cocaine
-
Liu XY, Chu XP, Mao LM et al.: Modulation of D2R-NR2B interactions in response to cocaine. Neuron 52(5), 897-909 (2006).
-
(2006)
Neuron
, vol.52
, Issue.5
, pp. 897-909
-
-
Liu, X.Y.1
Chu, X.P.2
Mao, L.M.3
-
47
-
-
57849133982
-
Mechanism of action of clozapine in the context of dopamine D1-D2 receptor hetero-dimerization - A working hypothesis
-
Dziedzicka-Wasylewska M, Faron-Gorecka A, Gorecki A, Kusemider M: Mechanism of action of clozapine in the context of dopamine D1-D2 receptor hetero-dimerization - a working hypothesis. Pharmacol. Rep. 60(5), 581-587 (2008).
-
(2008)
Pharmacol. Rep.
, vol.60
, Issue.5
, pp. 581-587
-
-
Dziedzicka-Wasylewska, M.1
Faron-Gorecka, A.2
Gorecki, A.3
Kusemider, M.4
-
48
-
-
48749132542
-
The role of D1-D2 receptor heterodimerization in the mechanism of action of clozapine
-
Faron-Gorecka A, Gorecki A, Kusmider M, Wasylewski Z, Dziedzicka-Wasylewska M: The role of D1-D2 receptor heterodimerization in the mechanism of action of clozapine. Eur. Neuropsychopharmacol. 18(9), 682-691 (2008).
-
(2008)
Eur. Neuropsychopharmacol.
, vol.18
, Issue.9
, pp. 682-691
-
-
Faron-Gorecka, A.1
Gorecki, A.2
Kusmider, M.3
Wasylewski, Z.4
Dziedzicka-Wasylewska, M.5
-
49
-
-
0026721811
-
Heteromeric NMDA receptors: Molecular and functional distinction of subtypes
-
Monyer H, Sprengel R, Schoepfer R et al.: Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256(5060), 1217-1221 (1992).
-
(1992)
Science
, vol.256
, Issue.5060
, pp. 1217-1221
-
-
Monyer, H.1
Sprengel, R.2
Schoepfer, R.3
-
50
-
-
0032912771
-
The glutamate receptor ion channels
-
Dingledine R, Borges K, Bowie D, Traynelis SF: The glutamate receptor ion channels. Pharmacol. Rev. 51(1), 7-61 (1999).
-
(1999)
Pharmacol. Rev.
, vol.51
, Issue.1
, pp. 7-61
-
-
Dingledine, R.1
Borges, K.2
Bowie, D.3
Traynelis, S.F.4
-
51
-
-
0026717250
-
Molecular diversity of the NMDA receptor channel
-
Kutsuwada T, Kashiwabuchi N, Mori H et al.: Molecular diversity of the NMDA receptor channel. Nature 358(6381), 36-41 (1992).
-
(1992)
Nature
, vol.358
, Issue.6381
, pp. 36-41
-
-
Kutsuwada, T.1
Kashiwabuchi, N.2
Mori, H.3
-
52
-
-
13344278706
-
Monozygotic twins concordant for response to clozapine
-
Vojvoda D, Grimmell K, Sernyak M, Mazure CM: Monozygotic twins concordant for response to clozapine. Lancet 347(8993), 61 (1996).
-
(1996)
Lancet
, vol.347
, Issue.8993
, pp. 61
-
-
Vojvoda, D.1
Grimmell, K.2
Sernyak, M.3
Mazure, C.M.4
-
53
-
-
0035703938
-
Association analysis for NMDA receptor subunit 2b (GRIN2B) genetic variants and psychopathology and clozapine response in schizophrenia
-
Hong CJ, Yu YW, Lin CH, Cheng CY, Tsai SJ: Association analysis for NMDA receptor subunit 2b (GRIN2B) genetic variants and psychopathology and clozapine response in schizophrenia. Psychiatr. Genet. 11(4), 219-222 (2001).
-
(2001)
Psychiatr. Genet.
, vol.11
, Issue.4
, pp. 219-222
-
-
Hong, C.J.1
Yu, Y.W.2
Lin, C.H.3
Cheng, C.Y.4
Tsai, S.J.5
-
54
-
-
0345411335
-
The ubiquitous nature of epistasis in determining susceptibility to common human diseases
-
Gene-gene interaction is a ubiquitous component of the genetic architecture of common human diseases and complex interactions are more important than the independent main effects of individual susceptibility genes
-
Moore JH: The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum. Hered. 56(1-3), 73-82 (2003). Gene-gene interaction is a ubiquitous component of the genetic architecture of common human diseases and complex interactions are more important than the independent main effects of individual susceptibility genes.
-
(2003)
Hum. Hered.
, vol.56
, Issue.1-3
, pp. 73-82
-
-
Moore, J.H.1
-
55
-
-
2442424229
-
Interaction between NOTCH4 and catechol-O-methyltransferase genotypes in schizophrenia patients with poor response to typical neuroleptics
-
Anttila S, Illi A, Kampman O, Mattila KM, Lehtimaki T, Leinonen E: Interaction between NOTCH4 and catechol-O-methyltransferase genotypes in schizophrenia patients with poor response to typical neuroleptics. Pharmacogenetics 14(5), 303-307 (2004).
-
(2004)
Pharmacogenetics
, vol.14
, Issue.5
, pp. 303-307
-
-
Anttila, S.1
Illi, A.2
Kampman, O.3
Mattila, K.M.4
Lehtimaki, T.5
Leinonen, E.6
-
56
-
-
77952422367
-
GSNO reductase and b2-adrenergic receptor gene-gene interaction: Bronchodilator responsiveness to albuterol
-
Choudhry S, Que LG, Yang Z et al.: GSNO reductase and b2-adrenergic receptor gene-gene interaction: bronchodilator responsiveness to albuterol. Pharmacogenet. Genomics 20(6), 351-358 (2010).
-
(2010)
Pharmacogenet. Genomics
, vol.20
, Issue.6
, pp. 351-358
-
-
Choudhry, S.1
Que, L.G.2
Yang, Z.3
-
58
-
-
33645993851
-
Dopamine D2 receptor gene variants and quantitative measures of positive and negative symptom response following clozapine treatment
-
Hwang R, Shinkai T, Deluca V et al.: Dopamine D2 receptor gene variants and quantitative measures of positive and negative symptom response following clozapine treatment. Eur. Neuropsychopharmacol. 16(4), 248-259 (2006).
-
(2006)
Eur. Neuropsychopharmacol.
, vol.16
, Issue.4
, pp. 248-259
-
-
Hwang, R.1
Shinkai, T.2
Deluca, V.3
-
59
-
-
0026080111
-
A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies
-
Lahiri DK, Nurnberger JI Jr.: A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 19(19), 5444 (1991).
-
(1991)
Nucleic Acids Res.
, vol.19
, Issue.19
, pp. 5444
-
-
Lahiri, D.K.1
Nurnberger Jr., J.I.2
-
60
-
-
0037382656
-
Association between the G1001C polymorphism in the GRIN1 gene promoter region and schizophrenia
-
Begni S, Moraschi S, Bignotti S et al.: Association between the G1001C polymorphism in the GRIN1 gene promoter region and schizophrenia. Biol. Psychiatry 53(7), 617-619 (2003).
-
(2003)
Biol. Psychiatry
, vol.53
, Issue.7
, pp. 617-619
-
-
Begni, S.1
Moraschi, S.2
Bignotti, S.3
-
61
-
-
69249231191
-
Association between the G1001C polymorphism in the GRIN1 gene promoter and schizophrenia in the Iranian population
-
Galehdari H, Pooryasin A, Foroughmand A, Daneshmand S, Saadat M: Association between the G1001C polymorphism in the GRIN1 gene promoter and schizophrenia in the Iranian population. J. Mol. Neurosci. 38(2), 178-181 (2009).
-
(2009)
J. Mol. Neurosci.
, vol.38
, Issue.2
, pp. 178-181
-
-
Galehdari, H.1
Pooryasin, A.2
Foroughmand, A.3
Daneshmand, S.4
Saadat, M.5
-
62
-
-
34548309202
-
Possible association between genetic variants at the GRIN1 gene and schizophrenia with lifetime history of depressive symptoms in a German sample
-
Georgi A, Jamra RA, Klein K et al.: Possible association between genetic variants at the GRIN1 gene and schizophrenia with lifetime history of depressive symptoms in a German sample. Psychiatr. Genet. 17(5), 308-310 (2007).
-
(2007)
Psychiatr. Genet.
, vol.17
, Issue.5
, pp. 308-310
-
-
Georgi, A.1
Jamra, R.A.2
Klein, K.3
-
63
-
-
0042821620
-
N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) in schizophrenia: TDT and case-control analyses
-
Martucci L, Wong AH, Trakalo J et al.: N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) in schizophrenia: TDT and case-control analyses. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 119B(1), 24-27 (2003).
-
(2003)
Am. J. Med. Genet. B. Neuropsychiatr. Genet.
, vol.119 B
, Issue.1
, pp. 24-27
-
-
Martucci, L.1
Wong, A.H.2
Trakalo, J.3
-
64
-
-
33645329090
-
Significant association between the genetic variations in the 5′ end of the N-methyl-D-aspartate receptor subunit gene GRIN1 and schizophrenia
-
Zhao X, Li H, Shi Y et al.: Significant association between the genetic variations in the 5′ end of the N-methyl-D-aspartate receptor subunit gene GRIN1 and schizophrenia. Biol. Psychiatry 59(8), 747-753 (2006).
-
(2006)
Biol. Psychiatry
, vol.59
, Issue.8
, pp. 747-753
-
-
Zhao, X.1
Li, H.2
Shi, Y.3
-
65
-
-
12444281048
-
A microsatellite repeat in the promoter of the N-methyl-D-aspartate receptor 2a subunit (GRIN2A) gene suppresses transcriptional activity and correlates with chronic outcome in schizophrenia
-
Promotor activity of plasmid constructs with repeat lengths of 25 or more were significantly lower than those with less than 25 repeats
-
Itokawa M, Yamada K, Yoshitsugu K et al.: A microsatellite repeat in the promoter of the N-methyl-D-aspartate receptor 2a subunit (GRIN2A) gene suppresses transcriptional activity and correlates with chronic outcome in schizophrenia. Pharmacogenetics 13(5), 271-278 (2003). Promotor activity of plasmid constructs with repeat lengths of 25 or more were significantly lower than those with less than 25 repeats.
-
(2003)
Pharmacogenetics
, vol.13
, Issue.5
, pp. 271-278
-
-
Itokawa, M.1
Yamada, K.2
Yoshitsugu, K.3
-
66
-
-
14844358507
-
Extended analyses support the association of a functional (GT)n polymorphism in the GRIN2A promoter with Japanese schizophrenia
-
Iwayama-Shigeno Y, Yamada K, Itokawa M et al.: Extended analyses support the association of a functional (GT)n polymorphism in the GRIN2A promoter with Japanese schizophrenia. Neurosci. Lett. 378(2), 102-105 (2005).
-
(2005)
Neurosci. Lett.
, vol.378
, Issue.2
, pp. 102-105
-
-
Iwayama-Shigeno, Y.1
Yamada, K.2
Itokawa, M.3
-
67
-
-
12244289624
-
Identification of a novel variant of the human NR2B gene promoter region and its possible association with schizophrenia
-
Luciferase reporter activity of plasmids with the GRIN2B T-200G T allele were significantly upregulated compared with that of the G allele
-
Miyatake R, Furukawa A, Suwaki H: Identification of a novel variant of the human NR2B gene promoter region and its possible association with schizophrenia. Mol. Psychiatry 7(10), 1101-1106 (2002). Luciferase reporter activity of plasmids with the GRIN2B T-200G T allele were significantly upregulated compared with that of the G allele.
-
(2002)
Mol. Psychiatry
, vol.7
, Issue.10
, pp. 1101-1106
-
-
Miyatake, R.1
Furukawa, A.2
Suwaki, H.3
-
68
-
-
33646535427
-
N-methyl-D-aspartate receptor NR2B subunit gene GRIN2B in schizophrenia and bipolar disorder: Polymorphisms and mRNA levels
-
Martucci L, Wong Ah, De Luca V et al.: N-methyl-D-aspartate receptor NR2B subunit gene GRIN2B in schizophrenia and bipolar disorder: polymorphisms and mRNA levels. Schizophr. Res. 84(2-3), 214-221 (2006).
-
(2006)
Schizophr. Res.
, vol.84
, Issue.2-3
, pp. 214-221
-
-
Martucci, L.1
Ah, W.2
De Luca, V.3
-
69
-
-
0344951296
-
D1 receptor alleles predict PET metabolic correlates of clinical response to clozapine
-
Potkin SG, Basile VS, Jin Y et al.: D1 receptor alleles predict PET metabolic correlates of clinical response to clozapine. Mol. Psychiatry 8(1), 109-113 (2003).
-
(2003)
Mol. Psychiatry
, vol.8
, Issue.1
, pp. 109-113
-
-
Potkin, S.G.1
Basile, V.S.2
Jin, Y.3
-
70
-
-
62749154560
-
Differential allelic expression of dopamine D1 receptor gene (DRD1) is modulated by microRNA mir-504
-
Huang W, Li MD: Differential allelic expression of dopamine D1 receptor gene (DRD1) is modulated by microRNA mir-504. Biol. Psychiatry 65(8), 702-705 (2009).
-
(2009)
Biol. Psychiatry
, vol.65
, Issue.8
, pp. 702-705
-
-
Huang, W.1
Li, M.D.2
-
71
-
-
0037320652
-
Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor
-
Duan J, Wainwright MS, Comeron JM et al.: Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum. Mol. Genet. 12(3), 205-216 (2003).
-
(2003)
Hum. Mol. Genet.
, vol.12
, Issue.3
, pp. 205-216
-
-
Duan, J.1
Wainwright, M.S.2
Comeron, J.M.3
-
72
-
-
70349102541
-
C957T polymorphism of dopamine D2 receptor gene affects striatal DRD2 in vivo availability by changing the receptor affinity
-
Hirvonen MM, Laakso A, Nagren K, Rinne JO, Pohjalainen T, Hietala J: C957T polymorphism of dopamine D2 receptor gene affects striatal DRD2 in vivo availability by changing the receptor affinity. Synapse 63(10), 907-912 (2009).
-
(2009)
Synapse
, vol.63
, Issue.10
, pp. 907-912
-
-
Hirvonen, M.M.1
Laakso, A.2
Nagren, K.3
Rinne, J.O.4
Pohjalainen, T.5
Hietala, J.6
-
73
-
-
0030933979
-
A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia
-
Arinami T, Gao M, Hamaguchi H, Toru M: A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum. Mol. Genet. 6(4), 577-582 (1997).
-
(1997)
Hum. Mol. Genet.
, vol.6
, Issue.4
, pp. 577-582
-
-
Arinami, T.1
Gao, M.2
Hamaguchi, H.3
Toru, M.4
-
74
-
-
0033009871
-
Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers
-
Jonsson EG, Nothen MM, Grunhage F et al.: Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol. Psychiatry 4(3), 290-296 (1999).
-
(1999)
Mol. Psychiatry
, vol.4
, Issue.3
, pp. 290-296
-
-
Jonsson, E.G.1
Nothen, M.M.2
Grunhage, F.3
-
75
-
-
79951866501
-
Allelic variation in the promoter region of the dopamine D2 receptor gene and clozapine response
-
Malhotra AK, Buchanan RW, Kim S, Kestler L, Breier A, Pickar D, Goldman D: Allelic variation in the promoter region of the dopamine D2 receptor gene and clozapine response. J. Sch. Res. 36(1-3), 2 (1999).
-
(1999)
J. Sch. Res.
, vol.36
, Issue.1-3
, pp. 2
-
-
Malhotra, A.K.1
Buchanan, R.W.2
Kim, S.3
Kestler, L.4
Breier, A.5
Pickar, D.6
Goldman, D.7
-
76
-
-
0031595664
-
The D2 dopamine receptor gene: A review of association studies in alcoholism and phenotypes
-
Noble EP: The D2 dopamine receptor gene: a review of association studies in alcoholism and phenotypes. Alcohol 16(1), 33-45 (1998).
-
(1998)
Alcohol
, vol.16
, Issue.1
, pp. 33-45
-
-
Noble, E.P.1
-
77
-
-
0037267659
-
Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics
-
Ritchie T, Noble EP: Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics. Neurochem. Res. 28(1), 73-82 (2003).
-
(2003)
Neurochem. Res.
, vol.28
, Issue.1
, pp. 73-82
-
-
Ritchie, T.1
Noble, E.P.2
-
78
-
-
9844233161
-
D2 dopamine receptor gene (DRD2) Taq1a polymorphism: Reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele
-
Thompson J, Thomas N, Singleton A et al.: D2 dopamine receptor gene (DRD2) Taq1a polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 7(6), 479-484 (1997).
-
(1997)
Pharmacogenetics
, vol.7
, Issue.6
, pp. 479-484
-
-
Thompson, J.1
Thomas, N.2
Singleton, A.3
-
79
-
-
0031752522
-
The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers
-
Pohjalainen T, Rinne JO, Nagren K et al.: The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol. Psychiatry 3(3), 256-260 (1998).
-
(1998)
Mol. Psychiatry
, vol.3
, Issue.3
, pp. 256-260
-
-
Pohjalainen, T.1
Rinne, J.O.2
Nagren, K.3
-
80
-
-
33746043780
-
A functional variant of the dopamine D3 receptor is associated with risk and age-at-onset of essential tremor
-
Jeanneteau F, Funalot B, Jankovic J et al.: A functional variant of the dopamine D3 receptor is associated with risk and age-at-onset of essential tremor. Proc. Natl Acad. Sci. USA 103(28), 10753-10758 (2006).
-
(2006)
Proc. Natl Acad. Sci. USA
, vol.103
, Issue.28
, pp. 10753-10758
-
-
Jeanneteau, F.1
Funalot, B.2
Jankovic, J.3
-
81
-
-
0030598907
-
Proposed schizophrenia-related gene polymorphism: Expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki forest virus system
-
Lundstrom K, Turpin MP: Proposed schizophrenia-related gene polymorphism: expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki forest virus system. Biochem. Biophys. Res. Commun. 225(3), 1068-1072 (1996).
-
(1996)
Biochem. Biophys. Res. Commun.
, vol.225
, Issue.3
, pp. 1068-1072
-
-
Lundstrom, K.1
Turpin, M.P.2
-
82
-
-
8744230049
-
The Ser9Gly SNP in the dopamine D3 receptor causes a shift from camp related to PGE2 related signal transduction mechanisms in transfected CHO cells
-
Hellstrand M, Danielsen EA, Steen VM, Ekman A, Eriksson E, Nilsson CL: The Ser9Gly SNP in the dopamine D3 receptor causes a shift from camp related to PGE2 related signal transduction mechanisms in transfected CHO cells. J. Med. Genet. 41(11), 867-871 (2004).
-
(2004)
J. Med. Genet.
, vol.41
, Issue.11
, pp. 867-871
-
-
Hellstrand, M.1
Danielsen, E.A.2
Steen, V.M.3
Ekman, A.4
Eriksson, E.5
Nilsson, C.L.6
-
83
-
-
0037336692
-
Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: Association study and meta-analysis
-
Jonsson EG, Flyckt L, Burgert E et al.: Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis. Psychiatr. Genet. 13(1), 1-12 (2003).
-
(2003)
Psychiatr. Genet.
, vol.13
, Issue.1
, pp. 1-12
-
-
Jonsson, E.G.1
Flyckt, L.2
Burgert, E.3
-
84
-
-
51249083462
-
Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia
-
Labrie V, Lipina T, Roder JC: Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia. Psychopharmacology (Berl.) 200(2), 217-230 (2008).
-
(2008)
Psychopharmacology (Berl.)
, vol.200
, Issue.2
, pp. 217-230
-
-
Labrie, V.1
Lipina, T.2
Roder, J.C.3
-
85
-
-
34347394551
-
Effects of (-)-stepholidine on NMDA receptors: Comparison with haloperidol and clozapine
-
Gu WH, Yang S, Shi WX, Zhen XC, Jin GZ: Effects of (-)-stepholidine on NMDA receptors: comparison with haloperidol and clozapine. Acta. Pharmacol. Sin. 28(7), 953-958 (2007).
-
(2007)
Acta. Pharmacol. Sin.
, vol.28
, Issue.7
, pp. 953-958
-
-
Gu, W.H.1
Yang, S.2
Shi, W.X.3
Zhen, X.C.4
Jin, G.Z.5
-
86
-
-
23744479575
-
STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating
-
Fradley RL, O'Meara GF, Newman RJ, Andrieux A, Job D, Reynolds DS: STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating. Behav. Brain. Res. 163(2), 257-264 (2005).
-
(2005)
Behav. Brain. Res.
, vol.163
, Issue.2
, pp. 257-264
-
-
Fradley, R.L.1
O'Meara, G.F.2
Newman, R.J.3
Andrieux, A.4
Job, D.5
Reynolds, D.S.6
-
87
-
-
0029910263
-
NMDA receptor mRNA correlation with antemortem cognitive impairment in schizophrenia
-
Humphries C, Mortimer A, Hirsch S, De Belleroche J: NMDA receptor mRNA correlation with antemortem cognitive impairment in schizophrenia. Neuroreport 7(12), 2051-2055 (1996).
-
(1996)
Neuroreport
, vol.7
, Issue.12
, pp. 2051-2055
-
-
Humphries, C.1
Mortimer, A.2
Hirsch, S.3
De Belleroche, J.4
-
88
-
-
0034094628
-
Glutamate receptor expression in schizophrenic brain
-
Meador-Woodruff JH, Healy DJ: Glutamate receptor expression in schizophrenic brain. Brain Res. Brain Res. Rev. 31(2-3), 288-294 (2000).
-
(2000)
Brain Res. Brain Res. Rev.
, vol.31
, Issue.2-3
, pp. 288-294
-
-
Meador-Woodruff, J.H.1
Healy, D.J.2
-
89
-
-
0033588176
-
Mice with reduced NMDA receptor expression display behaviors related to schizophrenia
-
Mohn AR, Gainetdinov RR, Caron MG, Koller BH: Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98(4), 427-436 (1999).
-
(1999)
Cell
, vol.98
, Issue.4
, pp. 427-436
-
-
Mohn, A.R.1
Gainetdinov, R.R.2
Caron, M.G.3
Koller, B.H.4
-
90
-
-
0035862965
-
Hyperfunction of dopaminergic and serotonergic neuronal systems in mice lacking the NMDA receptor e1 subunit
-
Miyamoto Y, Yamada K, Noda Y, Mori H, Mishina M, Nabeshima T: Hyperfunction of dopaminergic and serotonergic neuronal systems in mice lacking the NMDA receptor e1 subunit. J. Neurosci. 21(2), 750-757 (2001).
-
(2001)
J. Neurosci.
, vol.21
, Issue.2
, pp. 750-757
-
-
Miyamoto, Y.1
Yamada, K.2
Noda, Y.3
Mori, H.4
Mishina, M.5
Nabeshima, T.6
-
91
-
-
0036174608
-
Dimerization: An emerging concept for g protein-coupled receptor ontogeny and function
-
Property of receptors is to form heterodimeric complexes with novel pharmacological, signaling and trafficking characteristics
-
Angers S, Salahpour A, Bouvier M: Dimerization: an emerging concept for g protein-coupled receptor ontogeny and function. Annu. Rev. Pharmacol. Toxicol. 42, 409-435 (2002). Property of receptors is to form heterodimeric complexes with novel pharmacological, signaling and trafficking characteristics.
-
(2002)
Annu. Rev. Pharmacol. Toxicol.
, vol.42
, pp. 409-435
-
-
Angers, S.1
Salahpour, A.2
Bouvier, M.3
-
92
-
-
0141788413
-
Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia
-
Abi-Dargham A, Moore H: Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia. Neuroscientist 9(5), 404-416 (2003).
-
(2003)
Neuroscientist
, vol.9
, Issue.5
, pp. 404-416
-
-
Abi-Dargham, A.1
Moore, H.2
-
93
-
-
72649087941
-
Heterodimerization of dopamine receptors: New insights into functional and therapeutic significance
-
Maggio R, Aloisi G, Silvano E, Rossi M, Millan MJ: Heterodimerization of dopamine receptors: new insights into functional and therapeutic significance. Parkinsonism. Relat. Disord. 15(Suppl. 4), S2-S7 (2009).
-
(2009)
Parkinsonism. Relat. Disord.
, vol.15
, Issue.SUPPL. 4
-
-
Maggio, R.1
Aloisi, G.2
Silvano, E.3
Rossi, M.4
Millan, M.J.5
-
94
-
-
37249074554
-
A novel dopamine receptor signaling unit in brain: Heterooligomers of D1 and D2 dopamine receptors
-
George SR, O'Dowd BF: A novel dopamine receptor signaling unit in brain: heterooligomers of D1 and D2 dopamine receptors. ScientificWorldJournal 7, 58-63 (2007).
-
(2007)
ScientificWorldJournal
, vol.7
, pp. 58-63
-
-
George, S.R.1
O'Dowd, B.F.2
-
95
-
-
0141853757
-
Calcium signaling dysfunction in schizophrenia: A unifying approach
-
Lidow MS: Calcium signaling dysfunction in schizophrenia: a unifying approach. Brain Res. Brain Res. Rev. 43(1), 70-84 (2003).
-
(2003)
Brain Res. Brain Res. Rev.
, vol.43
, Issue.1
, pp. 70-84
-
-
Lidow, M.S.1
-
96
-
-
67349166946
-
Detecting gene-gene interactions that underlie human diseases
-
Utility and challenges in methods for detection and assessment of statistical gene-gene interactions
-
Cordell HJ: Detecting gene-gene interactions that underlie human diseases. Nat. Rev. Genet. 10(6), 392-404 (2009). Utility and challenges in methods for detection and assessment of statistical gene-gene interactions.
-
(2009)
Nat. Rev. Genet.
, vol.10
, Issue.6
, pp. 392-404
-
-
Cordell, H.J.1
|